Bexarotene

FDA Approved: * August 12, 2014
Pharm Company: * BANNER PHARMACAPS
Category: Cancer

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Bexarotene Overview

Bexarotene (brand name: Targretin) is an antineoplastic (anti-cancer) agent approved by the U.S.Food and Drug Administration (FDA) (in late 1999) and the European Medicines Agency (EMA) (early 2001) for use as a treatment for cutaneous T cell lymphoma (CTCL).[1] It is a third-generation retinoid. Contents 1 Medical uses 2 Contraindications 3 Adverse effects 4 Interactions 5 Mechanism 6 Physical properties 7 History 8 References Medical uses Bexarotene is indicated for...

Read more Bexarotene Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Bexarotene

Recent Bexarotene Forums: RSS Feed

Bexarotene for Alzheimer's

Hi - has anyone else heard about the research being done on Bexarotene as a viable Alzheimer's treatment? Apparently they have been testing it in mice and it appears to quickly and effectively stop (and even reverse) degeneration in the brain tissue. They basically took mice which were genetically engineered to exhibit Alzheimer's symptoms (yeah, cruel, I know) and observed how their brains would get built up with amyloid beta peptides (which are basically thought to exist in excess as plaque in the brains of people suffering from Alzheimer's and it causes the blocking up of neurons and cell death). And of course the mice would exhibit some of the classic early signs such as forgetfulness. Anyways, Scientific American has described some of the findings: "with just a sing...

Updated

Possible Dosages for this and Related Drugs:

Bexarotene
  • Capsule: 75mg
  • Gel: 1%
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Bexarotene: (7 results)

Sorted by National Drug Code
  • 0378-6955 Bexarotene 75 mg Oral Capsule, Liquid Filled by Mylan Pharmaceuticals Inc.
  • 0832-0285 Bexarotene 75 mg Oral Capsule by Upsher-smith Laboratories, Inc.
  • 42292-007 Bexarotene 75 mg Oral Capsule, Liquid Filled by Mylan Institutional Inc.
  • 43975-315 Bexarotene 75 mg Oral Capsule, Liquid Filled by Amerigen Pharmaceuticals Inc.
  • 68682-002 Bexarotene 1 g/100g Topical Gel by Oceanside Pharmaceuticals
  • 68682-003 Bexarotene 75 mg Oral Capsule, Liquid Filled by Oceanside Pharmaceuticals
  • 69238-1250 Bexarotene 75 mg Oral Capsule by Amneal Pharmaceuticals LLC

Other drugs which contain Bexarotene or a similar ingredient: (1 result)

Related Bexarotene Topics:

Bexarotene for Alzheimer's
Hi - has anyone else heard about the research being done on Bexarotene as a viable Alzheimer's treatment? Apparently... 4 replies




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 17 October 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA